With regards to the anti-tumor effects of the tumor Ag-specific human CD8+ T cells both in vivo and in vitro, we are planning to determine whether NP formulation is able to induce such tumoricidal human CD8+ T cells in HIS-CD8/NKT mice using an appropriate tumor model in the near future. The gene discussed is CD8A; the disease is neoplasm.